Tele-intensive Care Unit Market Trends and Growth Forecasts, 2025-2035 - Open-With-Consultant Model Dominates Tele-ICU Market Revenues While Intensivist Segment Gains Momentum
January 15, 2025 06:24 ET
|
Research and Markets
Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Tele-intensive Care Unit Market by Component, Type, End-user, and Region" report has been added to ResearchAndMarkets.com's offering. This...
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
January 06, 2025 07:00 ET
|
CytoSorbents
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai, United Arab Emirates, a Gateway to the Middle East and Africa
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
December 12, 2024 07:00 ET
|
CytoSorbents
CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.
CytoSorbents Announces Rights Offering
December 09, 2024 07:00 ET
|
CytoSorbents
CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
November 11, 2024 07:30 ET
|
CytoSorbents; Converge Biotech
CytoSorbents and Converge Biotech Partner In India to Expand CytoSorb Blood Purification Availability to Treat Sepsis and Other Deadly Conditions
BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
October 22, 2024 00:30 ET
|
BioAegis Therapeutics
Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is an immune system regulator that interrupts the...
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
October 17, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Announce Q3 2024 Financial and Operating Results on November 7, 2024
U.S. Tele-Intensive Care Unit Market Focused Insights 2024-2029: Integration of AI & ML In Virtual ICU Systems, Collaborations And Partnerships Between Virtual ICU Providers & Healthcare Organizations
August 08, 2024 06:54 ET
|
Research and Markets
Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "U.S. Tele-Intensive Care Unit Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Tele-Intensive...
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 30, 2024 02:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 29, 2024 08:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"